Liver-specific activation of NFĸβ has been demonstrated to induce hepatic insulin resistance in mice [75], and pGz has been demonstrated to reduce iNOS and NFĸβ expression [76,77]. This evidence concerns the gene NOS2 and Insulin resistance.